Publication not explained
Read the Original
This page is a summary of: The Catalytic DNA Topoisomerase II Inhibitor Dexrazoxane (ICRF-187) Induces Differentiation and Apoptosis in Human Leukemia K562 Cells, Molecular Pharmacology, March 2001, American Society for Pharmacology & Experimental Therapeutics (ASPET), DOI: 10.1124/mol.59.3.453.
You can read the full text:
Be the first to contribute to this page